ArticleEuropean journal of clinical pharmacology2023

Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database.

Laëtitia Gosselin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.